• Citer

A randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphoma

par Bosly, André;Grigg, Andrew;Holte, Harald;Gisselbrecht, Christian;Radford, John;Rossi, Andrea;Lopez-Guillermo, Armando;Trneny, Marek;Sebban, Catherine;Hagberg, Hans;da Costa, Fernando Leal;Colombat, Philippe;Bron, Dominique ;Coiffier, Bertrand
Référence The oncologist, 18, 11, page (1189)
Publication Publié, 2013

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	A randomized study of interferon α-2b versus no treatment as consolidation after high dose therapy and autologous stem cell transplantation for patients with relapsed lymphoma
Auteur:	Bosly, André; Grigg, Andrew; Holte, Harald; Gisselbrecht, Christian; Radford, John; Rossi, Andrea; Lopez-Guillermo, Armando; Trneny, Marek; Sebban, Catherine; Hagberg, Hans; da Costa, Fernando Leal; Colombat, Philippe; Bron, Dominique; Coiffier, Bertrand
Informations sur la publication:	The oncologist, 18, 11, page (1189)
Statut de publication:	Publié, 2013
Sujet CREF:	Cancérologie
MeSH keywords:	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Combined Modality Therapy
	Consolidation Chemotherapy
	Disease Progression
	Disease-Free Survival
	Female
	Humans
	Interferon-alpha -- therapeutic use
	Lymphoma -- drug therapy -- surgery
	Male
	Middle Aged
	Prospective Studies
	Recombinant Proteins -- therapeutic use
	Recurrence
	Stem Cell Transplantation -- methods
	Transplantation Conditioning -- methods
	Transplantation, Autologous
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1083-7159
	info:doi/10.1634/theoncologist.2013-0223
	info:pii/theoncologist.2013-0223
	info:scp/84887420090
	info:pmid/24105750
	PMC3825302